Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Diacerein in Psoriasis Vulgaris
NCT07352306Phase 4Recruiting
- Start
- Apr 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of AC-203 in Psoriasis vulgaris (PV). Started Apr 2026; status: recruiting.
02
Drugs
AC-203
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT07352306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07352306.